Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s): FENC

Healthcare Biotechnology

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase 3 clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6. It has established Fennec HEARS, a single source program designed to connect PEDMARK patients.

TSX:FRX - Post by User

Fennec Pharmaceuticals Ord Shs

Bullboard Posts

Comment by dipstick8on Jul 29, 2001 6:35pm

934 Views

Post# 4039179

RE: Irritating

Something doesn't seem right with this deal at all. I am still not sure if I got screwed buy Canaccord or if they got screwed themselves. I am confident that my broker had nothing to do with this at all, however not so sure about the IPO as a whole, I was told by someone the day before the IPO that that he could get as much stock at 1.50 or less. Seems fishy to me as I was told the IPO was over subsribed. How did this other guy know this was going to open less than the IPO price the day before it actually opened. I bought 10000 shares at 1.50 ($15000) now worth 6700 in less than 2 months!!!! Guess your not the only one to get suckered.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading